CURRENT PERSPECTIVE ON CHRONIC OBSTRUCTIVE PULMONARY DISEASE: FROM RISK FACTORS TO MULTIMORBIDITY
Transbaikalian Medical Bulletin · 30.07.2026 · (2) · 153-161
DOI: 10.52485/19986173_2026_2_153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transbaikalian Medical Bulletin, online erschienen am 30.07.2026. Verfasst von А. V Pashkevich und 1 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben.
Themen: COPD
Abstract (Originalsprache)
Chronic obstructive pulmonary disease (COPD) is a complex disorder involving multiple contributing factors. COPD risk factors encompass various aspects of modern life. Special attention is given to environmental exposure, occupational hazards and socio-economic conditions. Tobacco smoke plays a pivotal role in disease development. The complex composition of tobacco smoke contains thousands of harmful substances that damage the airways and lung tissue. Comorbid conditions significantly impact the course of COPD. Considering all disease aspects is essential for a comprehensive treatment approach. Interdisciplinary collaboration among specialists from various fields is an essential prerequisite for successful disease management. The review examines contemporary aspects of multifactorial aspects and multimorbidity in COPD.
Zitieren
APA
Pashkevich, А. V., & Belyakova, Е. А. (2026). CURRENT PERSPECTIVE ON CHRONIC OBSTRUCTIVE PULMONARY DISEASE: FROM RISK FACTORS TO MULTIMORBIDITY. Transbaikalian Medical Bulletin, 153-161. https://doi.org/10.52485/19986173_2026_2_153
Vancouver
Pashkevich АV, Belyakova ЕА. CURRENT PERSPECTIVE ON CHRONIC OBSTRUCTIVE PULMONARY DISEASE: FROM RISK FACTORS TO MULTIMORBIDITY. Transbaikalian Medical Bulletin. 2026:153-161. doi:10.52485/19986173_2026_2_153
BibTeX
@article{Pashkevich2026,
author = {Pashkevich, А. V and Belyakova, Е. А.},
title = {CURRENT PERSPECTIVE ON CHRONIC OBSTRUCTIVE PULMONARY DISEASE: FROM RISK FACTORS TO MULTIMORBIDITY},
journal = {Transbaikalian Medical Bulletin},
year = {2026},
number = {2},
pages = {153--161},
doi = {10.52485/19986173_2026_2_153}
}
EUVIMED